Novolog (pharm Up 1966) Ltd.TASE: NVLG

NVLG: Revenue up 31.8% year-over-year, net income and Adjusted EBITDA both increased significantly

· Issued by Novolog (pharm Up 1966) Ltd.

Revenue rose 31.8% year-over-year to ₪1.64 billion, with net income at ₪11.9 million and Adjusted EBITDA up 24%. Three dividends totaling ₪40 million were declared, and a new strategic plan was launched.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Earlier from Novolog (pharm Up 1966)

All Novolog (pharm Up 1966) news releases